Skip to main content
. 2020 May 19;112(12):1213–1221. doi: 10.1093/jnci/djaa040

Figure 1.

Figure 1.

Prevalence of mutations in women with any breast cancer, estrogen receptor-negative (ER-neg) breast cancer, and ER-positive (ER-pos) breast cancer, according to age (in years) at diagnosis and first-degree family history (FHx) of breast cancer. *Any mutation indicates any pathogenic mutation in 12 known breast cancer predisposition genes (ATM, BARD1, BRCA1, BRCA2, CDH1, CHEK2, NF1, PALB2, PTEN, RAD51C, RAD51D, and TP53).